Surgery News and Research

RSS

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

10 Jul 2020

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

U.S. Senators Bill Cassidy (R-La.) and Thomas Carper (D-Del.) are calling on the Centers for Medicare & Medicaid Services to lift regulations that deny insurance coverage for obesity drugs and that limit coverage of Intensive Behavioral Therapy amid the COVID-19 pandemic.

10 Jul 2020

Children with MED-EL Synchrony cochlear implant can safely undergo MRI without discomfort

A study from Ann & Robert H. Lurie Children's Hospital of Chicago found that children with a MED-EL Synchrony cochlear implant device can undergo MRI safely, with no discomfort and reduced need for sedation or anesthesia. Findings were published in the peer-reviewed journal Laryngoscope.

9 Jul 2020

Promising new approach uses natural killer cells to treat glioblastomas

Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading to death for most patients within 12-18 months of diagnosis.

9 Jul 2020

OU researcher receives $1.3 million grant to study stress-induced irritable bowel syndrome

Anyone who suffers from irritable bowel syndrome can testify to its signature trait: It gets worse during times of stress.

9 Jul 2020

Mass psychogenic illness identified as the likely cause of Havana Syndrome

Dozens of embassy staff reported an array of complaints that have baffled the medical community, the most prominent being concussion-like symptoms without head trauma.

9 Jul 2020

As COVID testing soars, wait times for results jump to a week — or more

Elliot Truslow went to a CVS drugstore on June 15 in Tucson, Arizona, to get tested for the coronavirus. The drive-thru nasal swab test took less than 15 minutes.

9 Jul 2020

ACTIONED consortium aims to transform future treatment of colorectal cancer patients

The Precision Medicine Centre of Excellence (PMC) at Queen's is leading a ground-breaking collaboration with the world's largest biotech company Roche, and Artificial Intelligence (AI) specialist, Sonrai Analytics.

9 Jul 2020

Amid surge, hospitals hesitate to cancel nonemergency surgeries

Three months ago, the nation watched as COVID-19 patients overwhelmed New York City's intensive care units, forcing some of its hospitals to convert cafeterias into wards and pitch tents in parking lots.

9 Jul 2020

New research can help overcome challenges in diabetes research

Scientists focused on finding better treatments or cures for types 1 or 2 diabetes are painfully aware of current limitations, including having to use animal tissue in studies that often don't translate to human trials.

9 Jul 2020

Lung physiology and immune function could spare children from severe COVID-19

Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.

8 Jul 2020

Study reveals how overactive immune cells aggravate heart valve disease

A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.

8 Jul 2020

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.

8 Jul 2020

Surgery News and Research

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

Children with MED-EL Synchrony cochlear implant can safely undergo MRI without discomfort

Promising new approach uses natural killer cells to treat glioblastomas

OU researcher receives $1.3 million grant to study stress-induced irritable bowel syndrome

Mass psychogenic illness identified as the likely cause of Havana Syndrome

As COVID testing soars, wait times for results jump to a week — or more

ACTIONED consortium aims to transform future treatment of colorectal cancer patients

Amid surge, hospitals hesitate to cancel nonemergency surgeries

New research can help overcome challenges in diabetes research

Lung physiology and immune function could spare children from severe COVID-19

Study reveals how overactive immune cells aggravate heart valve disease

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

COVID-19 pandemic has major impact on aesthetic implant market, says GlobalData

Surgical delay linked to increased risk in gastrointestinal malignancies, study finds

Unique photonic device could pave the way for a breakthrough in medical implants

COVID catch-22: They got a big ER bill because hospitals couldn’t test for virus

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

Researchers identify immune cell that predicts transplant patient's risk of organ rejection

Researchers discover novel class of safer analgesics

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News